Socioeconomic status and chronic diseases: The case of hypertension in China X Lei, N Yin, Y Zhao China Economic Review 23 (1), 105-121, 2012 | 53 | 2012 |
The impact of venture capital on innovation R Dessí, N Yin | 46 | 2012 |
Pharmaceuticals, incremental innovation and market exclusivity N Yin Toulouse School, 2012 | 24* | 2012 |
Examining firm responses to R&D policy: An analysis of pediatric exclusivity MK Olson, N Yin American Journal of Health Economics 4 (3), 321-357, 2018 | 16 | 2018 |
Venture capital and knowledge transfer R Dessi, N Yin CEPR Discussion Paper No. DP10421, 2015 | 14 | 2015 |
SES health gradients during the epidemiological transition: The case of China X Lei, N Yin, Y Zhao IZA Discussion Papers, 2010 | 6 | 2010 |
New clinical information and physician prescribing: How do pediatric labeling changes affect prescribing to children? MK Olson, N Yin Health Economics 30 (1), 144-164, 2021 | 4 | 2021 |
Venture capital, patents and innovation R Dessi, N Yin Working paper, 2011 | 4 | 2011 |
Multitask assignments with adverse selection M Xu, N Yin, S Li Economics Letters 181, 127-132, 2019 | 3 | 2019 |
Examining Firm Responses to Innovation Policy: An Analysis of Pediatric Exclusivity MK Olson, N Yin Working Paper, 2016 | 1 | 2016 |
Impact of Antitrust Regulations on Firm Market Value: Evidence from Chinese and US Internet Platforms BY Huang, N Yin, VY Zhang, S Zhao Huang, Y., Yin, N., Zhang, VY, Zhao, S.(2023). The Impact of Antitrust …, 2022 | | 2022 |
Do Firms Respond Opportunistically to Innovation Policy? An Analysis of Pediatric Exclusivity MK Olson, N Yin | | 2015 |
Influences on the Demand and Supply of Pediatric Studies: An Analysis of Pediatric Exclusivity MK Olson, N Yin | | 2015 |
Essays on the economics of innovation and intellectual property rights N Yin | | 2013 |
SES Gradients in the Prevalence, Awareness, Control and Suffering of Chronic Diseases: A Case of Chinese Hypertension X Lei, N Yin, Y Zhao | | 2009 |